GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dignitana AB (OSTO:DIGN) » Definitions » Cyclically Adjusted Price-to-FCF

Dignitana AB (OSTO:DIGN) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Dignitana AB Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Dignitana AB Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Dignitana AB's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dignitana AB Cyclically Adjusted Price-to-FCF Chart

Dignitana AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dignitana AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Dignitana AB's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Dignitana AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dignitana AB's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dignitana AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Dignitana AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

Dignitana AB Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Dignitana AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Dignitana AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.009/132.8245*132.8245
=-0.009

Current CPI (Mar. 2025) = 132.8245.

Dignitana AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.117 99.995 -0.155
201509 -0.133 100.228 -0.176
201512 0.000 100.276 0.000
201603 -0.304 100.751 -0.401
201606 -0.195 101.019 -0.256
201609 -0.357 101.138 -0.469
201612 -0.309 102.022 -0.402
201703 -0.720 102.022 -0.937
201706 -0.621 102.752 -0.803
201709 -0.507 103.279 -0.652
201712 -0.236 103.793 -0.302
201803 -0.381 103.962 -0.487
201806 -0.281 104.875 -0.356
201809 -0.106 105.679 -0.133
201812 -1.062 105.912 -1.332
201903 -0.187 105.886 -0.235
201906 -0.156 106.742 -0.194
201909 -0.284 107.214 -0.352
201912 -0.341 107.766 -0.420
202003 -0.325 106.563 -0.405
202006 -0.090 107.498 -0.111
202009 -0.172 107.635 -0.212
202012 -0.156 108.296 -0.191
202103 -0.172 108.360 -0.211
202106 -0.265 108.928 -0.323
202109 -0.206 110.338 -0.248
202112 -0.200 112.486 -0.236
202203 -0.018 114.825 -0.021
202206 -0.115 118.384 -0.129
202209 -0.053 122.296 -0.058
202212 -0.126 126.365 -0.132
202303 -0.039 127.042 -0.041
202306 -0.077 129.407 -0.079
202309 -0.017 130.224 -0.017
202312 -0.027 131.912 -0.027
202403 -0.038 132.205 -0.038
202406 -0.062 132.716 -0.062
202409 0.030 132.304 0.030
202412 0.014 132.987 0.014
202503 -0.009 132.825 -0.009

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dignitana AB  (OSTO:DIGN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Dignitana AB Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Dignitana AB's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Dignitana AB Business Description

Traded in Other Exchanges
Address
Traktorgranden 3, Lund, SWE, 226 60
Dignitana AB is a medical technology company, that develops, produces, and markets The DigniCap Scalp Cooling System. It is a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy to improve well-being and quality of life. Geographically, it derives a majority of revenue from the USA.

Dignitana AB Headlines

No Headlines